Mammography has been the standard for breast cancer screening for decades, but is still struggles where the need is growing. Younger women with dense breast tissue are facing unreliable results, since fibroglandular tissue can mask a cancer entirely.
Alexander Antrobus' device uses impedance sensing rather than X-rays, meaning no radiation, low cost, and small enough to sit in a GP clinic. Alex built the company's machine learning core before stepping up to lead the business, and in this episode of the GS MedTech Podcast, he shares:
🟠 what the technology's first-in-human study proved
🟠 why the team rebuilt the hardware after listening to the clinicians using it
🟠 the regulatory strategy behind targeting breast density before cancer detection
🟠 why MedTech looks slow to LPs, and more!
🔗 Discover Zedsen
🎧 Listen on Spotify
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Interested in joining us on the GS MedTech Podcast, or looking for talent advisory for your team? Get in touch
